Brief: Newron Pharmaceuticals H1 net loss widens to EUR 8.8 mln

Newron Pharmaceuticals SpA

15/09/2016 06:00

Sept 15 (Reuters) - Newron Pharmaceuticals SpA  NWRN.S : 
    * Confirm our outlook for full-year 2016 provided in March 
    * For first six months of this year, net research and 
development expenses were 8.2 million euros  ($9.22 million), up 
from 2015 expenses of 4.7 million euros 
    * Newron's net loss for first six months of 2016 is 8.8 
million euros, compared to 6.9 million euros in first half of 
2015 
    * Company's revenues for first half of 2016 were 3.9 million 
euros, up from 2.0 million euros in 2015 
 
     
     
Source text for Eikon:  ID:nTENsljxxa  
Further company coverage:  NWRN.S  
 
($1 = 0.8896 euros) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))